BD - News & Events


April 09, 2014
New Assay for Neisseria gonorrhoeae (GC) Testing Incorporates Real-Time PCR Technology

March 24, 2014
Dr. Claire Pomeroy Elected as BD Director

March 19, 2014
New RSV Test Provides Healthcare Providers Objective Results in Minutes

February 25, 2014
Healthcare Providers Can Diagnose Group A Strep in Minutes with New Test

February 14, 2014
BD Onclarity™ HPV Assay on the BD Viper™ LT System Achieves CE-IVD Mark

February 11, 2014
New Public-Private Alliance to Strengthen TB Laboratories in Indonesia

February 07, 2014
BD to Present at Investor Healthcare Conferences

February 07, 2014
Leading Industry Analyst Amit Bhalla Joins BD as Vice President, Global Strategy and Development

February 04, 2014
BD Announces Results for 2014 First Fiscal Quarter

January 28, 2014
BD Board Declares Dividend

January 14, 2014
BD Announces Webcast of Annual Meeting of Shareholders

January 13, 2014
New Laboratory Test Helps Hospitals Detect Newly Emerging Strains of Drug-Resistant Superbug

January 07, 2014
BD Acquires Alverix, Inc.

January 07, 2014
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call

December 03, 2013
Novel Molecular Assay for Patient Screening Detects S. aureus and Newly Emerging MRSA Strains Available in the United States

November 26, 2013
BD Board Increases Dividend

November 19, 2013
Rapid Delivery Program Product Portfolio Expands to Biopharmaceutical Injectable Market

November 13, 2013
New Collaboration with Industrial Customer Expands NPPD's Renewable Energy Portfolio

November 12, 2013
BD Joins National Patient Safety Foundation Corporate Council, Furthers Commitment to Safety

November 11, 2013
Novel Molecular Assay for MRSA Active Surveillance Detects Newly Discovered Strains of Drug-Resistant Superbug

November 06, 2013
BD Diagnostics Presents Integrated Cervical Cancer Testing Solutions at EUROGIN 2013

November 05, 2013
BD Announces Results for 2013 Fourth Fiscal Quarter and Full Year; Provides Fiscal 2014 Guidance

November 04, 2013
BD Rx Announces FDA Approval of High-Demand Injectable for Pain Management

November 04, 2013
New Collaboration Aims to Detect More TB Cases in Developing Countries

October 28, 2013
BD Launches BD Helping Build Healthy CommunitiesSM with Direct Relief and the National Association of Community Health Centers

October 16, 2013
BD Diagnostics and Sartorius Stedim Biotech Strengthen Cooperation in the Area of Microbiological Diagnostics

September 27, 2013
World Health Organization and BD Announce New Commitment to Address Maternal and Newborn Mortality

September 27, 2013
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call

September 20, 2013
Jury Returns Verdict in RTI vs. BD Lawsuit

September 05, 2013
New Workflow to Provide Scientists with Tools That Enable Single Cell Analysis for Oncology, Immunology and Stem Cell Research

September 02, 2013
Novel Molecular Assay for Pre-Surgical Screening Detects Newly Discovered MRSA Strains

August 30, 2013
BD to Present at Investor Healthcare Conferences

August 29, 2013
FDA Approves Third Drug in BD Simplist™ Prefilled Injectable Line of Products

August 27, 2013
BD ProbeTec™ Trichomonas vaginalis Qx Assay Launches on the BD Viper™ System with XTR™ Technology in the United States

August 26, 2013
BD Supports the FDA’s Proposal to Reclassify Rapid Influenza Tests

August 12, 2013
New Syringe Designed to Position More Large Volume Injectable Drugs for Prefill Administration

August 01, 2013
BD Announces Results for 2013 Third Fiscal Quarter

July 29, 2013
BD and the College of American Pathologists Announce Strategic Alliance to Support Laboratory Quality and Performance in India and China

July 23, 2013
BD Board Declares Dividend

July 08, 2013
BD Appoints Christopher Reidy as Chief Financial Officer

July 03, 2013
BD Announces Live Webcast Of Third Fiscal Quarter Earnings Conference Call

June 24, 2013
Menu of Partner Assays for the BD MAX™ System Continues to Expand in Europe

June 21, 2013
BD’s Latest Pen Needle Innovation Designed to Make Injections Easier for People with Diabetes

June 19, 2013
New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research

June 18, 2013
JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes

June 06, 2013
BD to Present at the Goldman Sachs 34th Annual Global Healthcare Conference

June 04, 2013
BD and Heart to Heart International Continue Ongoing Collaboration to Help Improve Healthcare in Haiti with Third Volunteer Service Trip

June 03, 2013
New Prefillable Syringe System Offers Advanced Glass Technology for Biopharmaceutical Injectable Drug Delivery

May 24, 2013
BD to Present at the Deutsche Bank 38th Annual Health Care Conference

May 22, 2013
BD Issues 2012 Sustainability Report

May 21, 2013
BD Board Declares Dividend

May 02, 2013
BD Announces Results for 2013 Second Fiscal Quarter

April 26, 2013
BD Diagnostics Advances Commitment to a Fully Integrated Microbiology Solution with New Agreement

April 22, 2013
FDA Approves Second Drug in BD Simplist™ Prefilled Injectable Line of Products

April 17, 2013
New Gastrointestinal Tract Infections Assays Launch in Europe

April 10, 2013
BD Announces FDA 510(k) Clearance and Commercial Launch of BD UltraSafe PLUS™ Passive Needle Guard

April 08, 2013
New Molecular Assay Provides Healthcare Facilities with a Simple, Efficient Way to Detect Dangerous Superbug

April 08, 2013
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call

April 07, 2013
CML HealthCare Inc. to Install North America's First and World's Largest Fully Automated BD Kiestra™ Microbiology Platform

March 27, 2013
BD Enters Pharmaceutical Industry with New Line of Generic Prefilled Injectable Products

March 13, 2013
BD Announces Appointment of Dr. Ellen Strahlman as Chief Medical Officer and Senior Vice President, Research & Development

March 12, 2013
BD Acquires Cato Software Solutions

February 27, 2013
Independent Study Published in Clinical Infectious Diseases Highlights the Importance of Antimicrobial Removal Systems in Blood Culture to Rapidly and Accurately Aid in the Diagnosis of Sepsis

February 27, 2013
BD to Present at Investor Healthcare Conferences

February 07, 2013
BD to Present at Investor Healthcare Conferences

February 05, 2013
BD Announces Results for 2013 First Fiscal Quarter

January 29, 2013
Catherine M. Burzik Elected as BD Director

January 29, 2013
BD Board Declares Dividend

January 23, 2013
BD Announces Webcast of Annual Meeting of Shareholders

January 15, 2013
BD PhaSeal™ System Receives Clearance from FDA Under Newly Created ONB Product Code

January 08, 2013
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call

December 26, 2012
BD Completes Acquisition of Safety Syringes, Inc.

December 21, 2012
BD to Present at Investor Healthcare Conferences

December 10, 2012
Medication Errors from Injectable Drugs Harm One Million Inpatients Each Year Adding Billions in Cost, New Study Finds

November 20, 2012
BD Board Increases Dividend by 10 Percent

November 07, 2012
BD Announces Results for 2012 Fourth Fiscal Quarter and Full Year

November 06, 2012
BD Announces Funding and Product Support for Hurricane Sandy Relief Efforts

November 06, 2012
BD Announces Appointment of William A. Kozy as Chief Operating Officer

November 01, 2012
BD Completes Sale of Majority of Discovery Labware Unit

October 31, 2012
First Partner Assay on the BD MAX™ System Launches in Europe

October 29, 2012
BD is Awarded WindMade™ Certification; Ranks Among Top 40 U.S. Companies in Newsweek's 2012 Green Rankings

October 17, 2012
New Molecular Test Available to Diagnose Trichomonas vaginalis in Asymptomatic and Symptomatic Females

October 12, 2012
BD and Lab21 Collaborate to Develop New Oncology Assays on the BD MAX™ Platform

October 11, 2012
New Disposable Pen Injector Offers Ease of Use as well as Customization Options for Use with a Wide Range of Injectable Drugs

October 10, 2012
BD Announces Chief Financial Officer Transition

October 02, 2012
New RSV Test Provides Reliable Results in Minutes

October 02, 2012
BD Announces Live Webcast Of Fourth Fiscal Quarter Earnings Conference Call

September 28, 2012
Leading Microbiology Expert Joins BD Diagnostics in Maryland

September 26, 2012
New Molecular Assay Detects Rapidly Emerging Multidrug-Resistant Superbug

September 20, 2012
New Influenza Test Offers Labs Advanced Performance and Reliable Results

September 19, 2012
BD Introduces Advanced Needle Technology Designed to Enhance Patient Comfort and Improve Patient Adherence in Diabetes Care

September 04, 2012
New Initiative to Advance Health Workers' Blood Collection Skills

August 27, 2012
BD Acquires Sirigen Group Limited

August 14, 2012
New Molecular Assay Allows Healthcare Facilities to Simplify Active Surveillance Testing for Deadly Superbug

August 02, 2012
BD Announces Results for 2012 Third Fiscal Quarter

July 26, 2012
BD and PEPFAR Launch Labs for Life to Strengthen Laboratories in Regions Heavily Burdened by Disease

July 25, 2012
BD Launches New Needle Designed to Improve Performance and Patient Comfort

July 24, 2012
BD Board Declares Dividend

July 23, 2012
BD Board of Directors Elects Rebecca W. Rimel

July 16, 2012
New Plastic Blood Culture Bottles Increase Lab Convenience While Maintaining High-Quality Standards

July 11, 2012
BD Announces Agreement to Acquire Safety Syringes, Inc.

July 09, 2012
New, Fully Automated BD MAX™ MRSA Assay Rapidly Identifies Patients Colonized with Deadly Superbug

June 28, 2012
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call

June 20, 2012
New, Affordable Flow Cytometer Cell Sorter Expands Access to Wider Range of Life Science Applications

June 07, 2012
JDRF and BD Collaborate to Develop More Accurate and Reliable Glucose Monitoring Devices for People with Type 1 Diabetes

May 30, 2012
BD to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference

May 23, 2012
BD Issues 2011 Sustainability Report

May 22, 2012
BD Board Declares Dividend

May 22, 2012
BD Appoints CEO Vincent A. Forlenza as Chairman of the Board

May 21, 2012
BD and Heart to Heart International Collaborate on Second Volunteer Service Trip to Help Improve Healthcare in Haiti

May 02, 2012
BD Opens Major Distribution Center in Four Oaks, North Carolina

May 02, 2012
BD to Present at Investor Healthcare Conferences

May 01, 2012
BD Announces Results for 2012 Second Fiscal Quarter

April 10, 2012
BD Signs Agreement to Sell Majority of Discovery Labware Unit
Advanced Bioprocessing Platform Excluded from Sale


April 02, 2012
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call

March 29, 2012
New Assay Rapidly Identifies Lethal Pathogen Responsible for Clostridium difficile Infection

March 27, 2012
New IVD Product is Designed to Improve Prevention and Control of GBS in Newborns

March 26, 2012
New Collaboration Aims to Improve Access to TB Diagnostics

March 09, 2012
BD to Present at the Barclays Capital Global Healthcare Conference

March 07, 2012
Study Shows Nurses are Exposed To Risks from Blood Exposure During Insertion and Removal of Peripheral IV Catheter

March 01, 2012
Nationwide Educational Tour Kicks Off on the Future of Molecular Diagnostics

February 13, 2012
BD Diagnostics Expands Portfolio with Automated Instrumentation Technologies to Offer Integrated Microbiology Lab Solutions

February 13, 2012
BD Acquires KIESTRA Lab Automation BV

February 13, 2012
First Specimen Collection Training Curriculum in Sub-Saharan Africa Launches at Kenyan Medical Training College

February 10, 2012
BD to Present at Investor Healthcare Conferences

February 07, 2012
Mesenchymal Stem Cells Have New Cell Culture Environment

February 06, 2012
BD Announces Results for 2012 First Fiscal Quarter

January 31, 2012
BD Board Declares Dividend

January 24, 2012
BD Announces Webcast of Annual Meeting of Shareholders

January 18, 2012
BD and Mercy/ROi Collaborate to Improve Quality of Care and Reduce Costs

January 11, 2012
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call

January 04, 2012
BD to Present at the 30th Annual J. P. Morgan Healthcare Conference

December 15, 2011
New BD Veritor™ System for Rapid Detection of Flu A+B Receives 510(k) Clearance and CLIA Waiver

November 23, 2011
First Healthcare-Associated Infection Assay on the BD MAX™ System Launches in Europe

November 22, 2011
BD Board Increases Dividend

November 22, 2011
BD to Present at the 23rd Annual Piper Jaffray Healthcare Conference

November 02, 2011
BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year

October 28, 2011
BD Announces 2011 Analyst Day and Webcast

October 27, 2011
BD Introduces the World's First Safety-Engineered Pen Needle With Passive, Dual-Ended Protection

October 04, 2011
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call

September 26, 2011
BD Biosciences Introduces New Device Designed to Increase Cell Growth and Cell Culture Productivity

September 21, 2011
BD Launches a New Generation Short Peripheral IV Catheter to Reduce Risk of Blood Exposure to Healthcare Workers

September 16, 2011
BD Celebrates 50 Years in Canaan, CT

September 13, 2011
BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative®

September 07, 2011
BD to Present at the 2011 Morgan Stanley Global Healthcare Conference

August 24, 2011
BD Biosciences Announces Winners of Research Grant Program

August 18, 2011
BD Diagnostics and Biodiversity Collaborate to Develop Portfolio of Assays on the BD MAX™ System

August 17, 2011
BD Manufacturing Facility in Broken Bow Achieves Company's Landfill-Free Status

August 16, 2011
BD Completes Acquisition of Carmel Pharma

August 15, 2011
BD Launches Family of Syringes Which Addresses Environmental Impact and Meets a Variety of Clinical Needs

August 03, 2011
BD and Lab21 Collaborate to Develop Aspergillus Assay for New BD MAX™ Molecular Testing System

August 02, 2011
BD Announces Results for 2011 Third Fiscal Quarter

July 27, 2011
BD Announces Agreement to Acquire Carmel Pharma, Inc.

July 26, 2011
BD Board Declares Dividend

July 26, 2011
BD Board of Directors Elects Vincent A. Forlenza as Next Chief Executive Officer, Effective October 1, 2011

July 12, 2011
BD Biosciences Announces Spring 2011 Winners of Research Grant Program

July 08, 2011
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call

July 07, 2011
SANYO and BD Biosciences Collaborate to Offer Researchers Valuable Technology and Research Tools

July 06, 2011
BD Diagnostics Hires Leading Infectious Disease Diagnostics Expert to Strengthen New Product Pipeline

June 29, 2011
BD Biosciences Introduces Chemically Defined Cell Culture Media Supplement that Increases Biopharmaceutical Protein Production

June 20, 2011
Healthcare Workers Learn Improved Blood Collection Skills

June 09, 2011
Winning Photographers Bring Hope for a Healthy World

June 09, 2011
BD and Heart to Heart International Launch Volunteer Service Trip to Help "Build Back Better" in Haiti

June 03, 2011
BD Celebrates Grand Opening of North American Professional Service Center in San Antonio, Texas

May 24, 2011
BD Board Declares Dividend

May 20, 2011
BD Biosciences Launches New Cell Analyzer to Streamline Research Workflow

May 19, 2011
BD Issues 2010 Sustainability Report

May 19, 2011
BD Launches BD MAX™ System in U.S. to Empower Laboratories and Clinicians to Respond to Emerging Diseases

May 09, 2011
BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX™ System

May 06, 2011
BD Launches BD MAX™ Open System in Europe and Reveals Strategy to Build Broad Menu of Assays that Provide Timely, Accurate Information to Laboratories and Clinicians

May 03, 2011
Resource Now Available to Help Clinicians Reduce Risk of Blood Exposure from Short Peripheral IV Catheter Insertion

April 28, 2011
BD to Present at Investor Healthcare Conferences

April 26, 2011
BD Announces Results for 2011 Second Fiscal Quarter

April 15, 2011
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call

April 14, 2011
BD Celebrates Expansion of Manufacturing Facility in Columbus, Nebraska

April 13, 2011
BD and Waste Management Launch Initiative to Recycle Medical Sharps

April 07, 2011
World Health Day Emphasis on Antimicrobial Resistance Brings Much-Needed Awareness to Alarming Issue

April 05, 2011
BD Update Regarding Operations in Japan

April 04, 2011
New CDC Guidelines Recognize Value of Split Septum IV Access Technology to Reduce Intravascular Catheter-Related Bloodstream Infections

March 28, 2011
BD Diagnostics Receives FDA Clearance for First Fully Automated Molecular Assays for HSV1 and HSV2 from Clinician-Collected External Anogenital Lesion Specimens

March 21, 2011
World TB Day Donation Campaign Increases Access to Improved TB Tests in Resource-Limited Settings

March 18, 2011
BD Completes Acquisition of Accuri Cytometers, Inc.

March 15, 2011
BD Statement Regarding Impact of Japan Earthquake

March 15, 2011
BD Donates $325,000 for Japan Earthquake and Tsunami Relief Efforts

February 16, 2011
BD Expands Industrial Microbiology Rapid Methods Portfolio

February 09, 2011
BD and UCL Business Reach Exclusive License Agreement to Advance Development of New Diagnostic Tests for Ovarian and Breast Cancers

February 08, 2011
CEO Ed Ludwig Discusses Q1 FY11 Results on CNBC

February 07, 2011
BD Announces Results for 2011 First Fiscal Quarter

February 07, 2011
BD Announces Agreement to Acquire Accuri Cytometers, Inc.

February 01, 2011
BD Board Declares Dividend

February 01, 2011
BD Announces Results of Shareholder Votes at Annual Meeting

January 24, 2011
BD and Rady Children's Hospital-San Diego Announce Innovative Pilot Project to Reduce Environmental Impact of Sharps Disposal

January 05, 2011
BD Announces Webcast of Annual Meeting of Shareholders

January 04, 2011
BD to Present at the 29th Annual J. P. Morgan Healthcare Conference

January 03, 2011
New Amplified Molecular Tests Promise to Help Improve Diagnosis and Treatment of Herpes Patients

December 20, 2010
BD Diagnostics Facility in Mebane, North Carolina Achieves LEED Silver Certification for Green Building Design

December 16, 2010
BD Biosciences Announces Winners of Research Grant Program

December 02, 2010
BD - Canada Headquarters in Mississauga, Ontario Achieves LEED Gold Certification for Environmentally Responsible Design, Construction and Operations

November 29, 2010
Hospitals Can Save 25 Percent in Component Costs and Significantly Improve Nurse Satisfaction

November 23, 2010
BD Board Increases Dividend

November 16, 2010
BD Taps Leading Voice in Infection Prevention Community to Advance Efforts to Reduce Healthcare-Associated Infections

November 03, 2010
BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year

November 02, 2010
UPDATE: BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call

October 25, 2010
BD Vacutainer® Rapid Serum Tube (RST) Helps Improve Healthcare Worker Safety, Patient Care and Hospital Productivity

October 25, 2010
BD Ranks Among Top 25 U.S. Companies in Newsweek's 2010 Green Rankings; Receives EPA Green Power Leadership Award; Named to Dow Jones Sustainability World Index for Fifth Consecutive Year

October 25, 2010
BD Diagnostics and Lonza Collaborate to Commercialize the Lonza microCompass™ Molecular Assays on the BD MAX™ System

October 14, 2010
BD Celebrates Grand Opening of New Bioscience Production Facility in Miami

October 14, 2010
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call

October 01, 2010
BD to Establish Major Distribution Center in Four Oaks, North Carolina

September 29, 2010
BD Diagnostics and Bruker Collaborate to Improve Microbial Identification and Antimicrobial Susceptibility Testing

August 03, 2010
BD Receives CLIA "Moderate Complexity" Status for the BD MAX™ GBS Assay

August 02, 2010
BD Completes Sales of Ophthalmic Systems Unit and Surgical Blades Product Platform

July 29, 2010
BD Announces Results for Third Quarter Fiscal 2010

July 29, 2010
CEO Ed Ludwig Appears on CNBC to Discuss Q310 Results

July 28, 2010
BD Announces Promotion of President Vince Forlenza; Gains Additional Title of Chief Operating Officer

July 28, 2010
BD Announces Appointment of Zachary A. Nagle as Vice President, Investor Relations

July 27, 2010
BD Board Declares Dividend

July 26, 2010
BD Board of Directors Elects Christopher Jones

July 19, 2010
BD Biosciences Introduces CD4 Testing Product That Does Not Require Refrigeration

July 07, 2010
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call

June 21, 2010
BD and PEPFAR Collaboration Initiates Program to Improve Blood-Drawing Practices in Clinics and Hospitals in Sub-Saharan Africa

June 17, 2010
Launch of BD BACTEC™ MGIT™ 320 System Expands TB Detection Worldwide

June 16, 2010
BD Biosciences to Fund $100,000 in Stem Cell Research Grants

June 09, 2010
BD to Present at Goldman Sachs 31st Annual Global Healthcare Conference

June 08, 2010
BD Signs Agreements to Sell Ophthalmic Systems Unit, Other Platforms

June 07, 2010
BD Launches World's Smallest Pen Needle

June 03, 2010
BD Issues 2009 Sustainability Report

June 03, 2010
BD Biosciences Announces Second Set of Winners of Expanded Research Grant Program

June 02, 2010
BD Announces First FDA-Cleared Assay on the BD MAX™ System to Detect Group B Streptococcus

June 01, 2010
BD Announces U.S. Launch of BD Vacutainer® Push Button Blood Collection Set with Pre-Attached Holder

May 25, 2010
BD Board Declares Dividend

May 20, 2010
BD Celebrates Opening of Manufacturing Facility in Mebane, North Carolina

May 07, 2010
BD Biosciences Launches Adaptable 7-Laser Flow Cytometry System for Advanced Research Applications

May 06, 2010
BD Reaffirms Commitment to GS1 Data Standards

May 05, 2010
BD to Present at Investor Healthcare Conferences

April 29, 2010
BD Announces Results for Second Quarter Fiscal 2010

April 14, 2010
BD Biosciences Launches New BD LSRFortessa™ Cell Analyzer

April 08, 2010
BD Celebrates Opening of New Manufacturing Facility in Tatabánya, Hungary

April 08, 2010
BD Announces Live Webcast of Second Quarter Fiscal 2010 Earnings Conference Call

April 06, 2010
BD Expands Diagnostics Portfolio with Advanced Automated Microbiology Specimen Processor

March 18, 2010
BD Diagnostics Launches the BD Protect™ Infection Surveillance and Prevention Software Portfolio

March 15, 2010
BD to Present at Barclays Capital 2010 Healthcare Conference

March 05, 2010
BD Named Industry Champion on FORTUNE's List of the "World's Most Admired Companies"

March 01, 2010
BD Celebrates Opening of New Manufacturing Facility in San Luis Potosi, Mexico

February 23, 2010
BD Biosciences Launches BD FACSAria™ III Flow Cytometry System

February 08, 2010
BD Announces Worldwide Voluntary Recall of BD Q-Syte™ Luer Access Devices and BD Nexiva™ Closed IV Catheter Systems

February 08, 2010
BD Launches New Device Designed to Improve Safety, Accuracy and Turnaround Time of Blood Collection in Patients with Fragile Veins

February 03, 2010
BD Launches "Be a Flu Fighter" Campaign to Promote Influenza Awareness and Prevention in Schools, Hospitals and Laboratories

February 02, 2010
BD Board Declares Dividend

February 02, 2010
BD Announces Results of Shareholder Votes at Annual Meeting

January 28, 2010
BD Announces Results for First Fiscal Quarter

January 27, 2010
BD Increases Haiti Relief Fund to Include $5 Million in Product Donations

January 19, 2010
JDRF and BD Collaborate to Improve Insulin Pump Delivery

January 15, 2010
BD Establishes $1.2 Million Fund for Haiti Earthquake Relief Efforts

January 14, 2010
BD Announces Webcast of Annual Meeting of Shareholders

January 11, 2010
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call

January 11, 2010
BD Biosciences Collaborates with ReaMetrix to Develop New, Affordable CD4 Testing Products to Help Fight HIV/AIDS in Developing Countries

January 08, 2010
BD Applauds PEPFAR's Broadened Emphasis On Strengthening Health Systems

December 29, 2009
BD to Present at Investor Healthcare Conferences

December 08, 2009
BD Biosciences Announces First Winners of Expanded Research Grant Program

December 07, 2009
BD Expands Diagnostic Testing Offerings in Women's Health

November 24, 2009
BD Board Increases Dividend and Authorizes Additional Share Repurchases

November 19, 2009
BD Completes Acquisition of HandyLab, Inc.

November 05, 2009
BD Diagnostics Launches Turnkey Continuing Education Program for Clinical Laboratories

November 04, 2009
BD to Present at Investor Healthcare Conferences

November 04, 2009
BD Announces Results for Fourth Fiscal Quarter and Full Year

October 30, 2009
BD Director Emeritus Henry P. Becton, Sr. Dies at 95

October 23, 2009
BD Announces Agreement to Acquire HandyLab, Inc.

October 07, 2009
BD Ranked in the Top 100 Greenest Big Companies by Newsweek; Named Again to Dow Jones Sustainability World and North America Indexes

October 06, 2009
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call

October 06, 2009
BD Announces FDA 510(k) Clearance of BD Vacutainer® Rapid Serum Blood Collection Tube

September 25, 2009
BD Receives Health Canada Approval for the BD FocalPoint™ GS Imaging System to Enhance the Detection of Cervical Cancer

September 14, 2009
BD Launches Expanded Line of BD Visitec™ Single-Use Microsurgical Instruments and Customized Trays

September 03, 2009
BD Announces Flu Product Order from U.S. Government

August 25, 2009
NBA Legend Dikembe Mutombo, UNICEF Executive Director Ann M. Veneman and BD Commemorate Opening of New Center to Improve HIV/AIDS Treatment in the DRC

August 12, 2009
BD Biosciences Expands Reagent and Dye Portfolio for Cellular Analysis

August 11, 2009
BD and PEPFAR Collaboration Will Improve Blood-drawing Practices in Hospitals and Clinics in Sub-Saharan Africa

August 06, 2009
BD Adds Surveillance Capability to Infectious Disease Portfolio

August 04, 2009
BD Biosciences Launches Laboratory Information System Interface Software for Labs Using BD Flow Cytometers

August 04, 2009
BD and Direct Relief International Team Up to Provide Free Diabetes Insulin Injection Products to Americans Impacted by the Economic Downturn

July 29, 2009
BD Announces Results for Third Fiscal Quarter

July 28, 2009
BD Board Declares Dividend

July 23, 2009
BD Flu Preparedness Statement

July 19, 2009
BD/PEPFAR Lab-Strengthening Initiative Marks Progress in Fight Against HIV/Aids and TB in Sub-Saharan Africa

July 09, 2009
New Flow Cytometry-based Methods for Stem Cell Research Presented at Annual International Society for Stem Cell Research Meeting

June 30, 2009
BD Biosciences Launches New Portfolio of Surfaces for Cell-Based Drug Discovery Screening and Basic Cell Culture Research

June 29, 2009
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call

June 17, 2009
BD and FIND Achieve Milestone in Global Battle Against MDR-TB

June 01, 2009
BD Biosciences Launches New Cell Analyzer for Complex Multicolor Experiments in Disease and Drug Development Research

June 01, 2009
BD to Present at Investor Healthcare Conferences

May 20, 2009
BD Board Declares Dividend

May 18, 2009
BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays

May 13, 2009
BD Biosciences Launches BD UltraPool™ HLM 150 Reagent

May 08, 2009
BD Extends Decade-Long Support for UNICEF's Campaign to Eliminate Maternal and Neonatal Tetanus

May 08, 2009
BD Biosciences Announces Winners of Annual Research Grant Program

May 08, 2009
BD Biosciences Expands Research Grant Program to Offer Researchers More Support During Tough Economic Times

May 04, 2009
BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management

April 28, 2009
BD Announces Results for Second Fiscal Quarter

April 01, 2009
American Red Cross of Northern New Jersey Honors BD and President Vince Forlenza during April's "Touch of Red" Virtual Fundraising Gala

April 01, 2009
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call

March 23, 2009
BD Announces FDA 510(k) Clearance of BD ProbeTec™ Qx Amplified Assays for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae

March 17, 2009
BD Launches BD OcuSeal™ Liquid Ocular Bandage

March 12, 2009
BD Joins Safe Injection Practices Coalition

March 11, 2009
BD Named to 100 Best Corporate Citizens List by CRO Magazine

March 11, 2009
BD Biosciences Facility in San Jose, California Achieves LEED Silver Certification

February 26, 2009
BD Soluvia™ Microinjection System Used For First Approved Intradermal Influenza Vaccine in the European Union

February 23, 2009
BD Ranks 23rd on EPA's Fortune 500 List of Green Power Purchasers

February 10, 2009
BD Announces CE Marking of BD ProbeTec™ Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae

February 03, 2009
BD Board Declares Dividend

February 03, 2009
BD Announces Results of Shareholder Votes at Annual Meeting

January 28, 2009
BD Announces Results for First Fiscal Quarter

January 14, 2009
New BD BACTEC™ FX Blood Culture System with the BD EpiCenter™ Operating System now Available Worldwide

January 14, 2009
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call

January 14, 2009
BD Announces Webcast of Annual Meeting of Shareholders

January 12, 2009
BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections

December 23, 2008
BD to Present at Investor Healthcare Conferences

December 15, 2008
BD Biosciences Launches BD™ Human Pluripotent Stem Cell Sorting and Analysis Kit

December 04, 2008
BD Receives FDA Approval for the BD FocalPoint™ GS Imaging System to Enhance the Detection of Cervical Cancer

December 01, 2008
BD Launches 8mm BD AutoShield™ Pen Needle

November 25, 2008
BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases

November 25, 2008
BD Biosciences Announces Availability of New CD4 Technology in Africa

November 21, 2008
BD Increases Production Capacity for BD SafetyGlide™ Needles and Other Safety-Engineered Injection Devices

November 20, 2008
BD Announces Health Canada Licensing of Novel Molecular Assay for Detection of Clostridium difficile Toxin B Gene

November 08, 2008
BD Launches BD Atomic Edge™ Safety LRI Knives

November 05, 2008
BD Announces Results for Fourth Fiscal Quarter and Full Year

November 05, 2008
BD Announces Executive Appointments of President and Chief Financial Officer

November 03, 2008
BD to Present at Investor Healthcare Conferences

October 22, 2008
Collaborative Partnership Formed to Improve the Health of Health Care Workers

October 13, 2008
United Nations Secretary-General Statement Regarding HIV/AIDS (PDF)

October 03, 2008
BD Sponsors Campaign to Raise Awareness of XDR-TB (Extensively Drug-Resistant Tuberculosis)

October 02, 2008
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call

October 02, 2008
BD Biosciences to Open New Animal-Free, Antibiotic-Free Cell Culture Media Manufacturing Facility

September 30, 2008
BD Breaks Ground on Major Manufacturing Facility in Tatabánya

September 25, 2008
Clinton Global Initiative Announces BD's Commitment To Biamba Marie Mutombo Hospital

September 23, 2008
Luminex and BD Sign Agreement to Create Diagnostic Tests for Cancer

September 10, 2008
BD Celebrates Opening of New Automated Warehouse in Fraga

July 24, 2008
BD Announces Results for Third Fiscal Quarter

July 22, 2008
BD Board Declares Dividend

July 07, 2008
BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections

June 25, 2008
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call

June 12, 2008
BD Biosciences and San Jose Mayor Celebrate Opening of State-of-the-Art Office Space and Customer Training Center

June 10, 2008
BD Celebrates Opening of New Manufacturing Center in Québec

June 04, 2008
BD Biosciences Earns Prestigious Life Science Industry Award for Best Flow Cytometry-based Cell Biology Instruments

June 03, 2008
BD to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference

June 02, 2008
New BD BACTEC™ FX Blood Culture Instrument with the BD EpiCenter™ Operating System can Facilitate Fast and Effective Clinical Decisions for Patients with Bacterial Infections

May 23, 2008
BD Biosciences Launches BD AttoVision™ Software v1.6

May 20, 2008
BD Board Declares Dividend

May 13, 2008
BD Announces Acquisition of Cytopeia

May 07, 2008
BD to Present at Investor Healthcare Conferences

May 01, 2008
BD Announces CE Marking of the BD GeneOhm™ VanR Molecular Test for the Rapid Detection of Vancomycin Resistance

May 01, 2008
BD Biosciences Announces Agreement with 3-D Matrix to Market BD™ PuraMatrix™ Peptide Hydrogel Products to the Research Community

April 23, 2008
BD Announces Results for Second Fiscal Quarter

April 08, 2008
BD Opens New Manufacturing Facility in Suzhou, China to Produce Rapid Diagnostic Products

April 04, 2008
BD Biosciences Announces Winners of 2007 Research Grant Program

April 03, 2008
BD Biosciences Launches New BD™ High-Performance Calcium Dye Assay Kit

March 27, 2008
BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana

March 26, 2008
BD Venflon™ Pro Safety Catheter Wins Award in Prestigious International Design Competition

March 26, 2008
BD to Present at the Leerink Swann Molecular Diagnostics Roundtable Conference

March 26, 2008
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call

March 18, 2008
BD Board of Directors Elects John R. Considine as Vice Chairman and Member of the Board of Directors

March 17, 2008
BD GeneOhm™ MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection Rates

February 13, 2008
First European Application Filed for Product Using Innovative Intradermal Microinjection System BD Soluvia™

January 29, 2008
BD Board Declares Dividend

January 29, 2008
BD Announces Results of Shareholder Votes at Annual Meeting

January 28, 2008
BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference

January 24, 2008
BD Announces Results for First Fiscal Quarter

January 18, 2008
BD Biosciences Launches New BD FACSAria™ II Cell Sorting System

January 16, 2008
BD Announces Webcast of Annual Meeting of Shareholders

January 04, 2008
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call

January 02, 2008
BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures

December 27, 2007
BD to Present at the 26th Annual JPMorgan Healthcare Conference

December 20, 2007
BD Announces CE Marking of Rapid Molecular Test to Identify Superbug from Nasal and Wound Specimens

December 18, 2007
UCLH Study Demonstrates Rapid Patient Screening Could Cut MRSA Rates By Almost 40 Per Cent

November 21, 2007
Next Generation of BD Visitec™ Disposable Instruments Designed to Meet the Needs of Ophthalmic Surgery

November 20, 2007
BD Board Declares Dividend

November 07, 2007
BD to Present at Investor Healthcare Conferences

November 05, 2007
BD and FIND Help Address Emergence of XDR-TB With New Pricing Agreement for Liquid Culture System

November 02, 2007
BD Board of Directors Elects Cathy E. Minehan

November 01, 2007
BD Announces Results For Fourth Fiscal Quarter and Full Year

October 31, 2007
BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB

October 22, 2007
CEO Ed Ludwig Discusses Healthcare-associated Infections on CNBC (Video)

October 09, 2007
BD Biosciences Opens Education Center in Rockville, Maryland for High-Content Bioimaging Customers

October 01, 2007
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call

September 11, 2007
BD Announces FDA 510(k) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery

September 08, 2007
New Ophthalmic Safety Knives with BD Atomic Edge™ Technology Approach Diamond-Like Sharpness and Single-Use Convenience

August 30, 2007
BD to Present at the Bear Stearns 20th Annual Healthcare Conference

August 06, 2007
BD Taps Seasoned Executive and Researcher to Serve as Company's Chief Technology Officer

July 26, 2007
BD Announces Results for Third Fiscal Quarter

July 26, 2007
BD to Expand European Distribution Center in Temse, Belgium

July 24, 2007
BD Board of Directors Elects Marshall O. Larsen

July 24, 2007
BD Board Declares Dividend and Authorizes Additional Share Repurchases

June 29, 2007
BD Biosciences Releases BD FACSDiva™ 6.0 Software

June 29, 2007
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call

June 28, 2007
BD Biosciences Announces 2007 Research Grant Program

June 15, 2007
BD Biosciences and StemCell Technologies Launch Advanced Culture Environment for Human Embryonic Stem Cell (hESC) Research

June 14, 2007
BD Medical - Ophthalmic Systems Celebrates 75 Years of Beaver Surgical Products

June 14, 2007
BD Biosciences and StemCell Technologies Sign License Agreements with WARF to Commercialize Novel Culture Media and Surfaces for Human Embryonic Stem Cell Research

June 04, 2007
BD and EPSC Announce Launch of specimencare.com

June 04, 2007
BD to Present at the Goldman Sachs Twenty-Eighth Annual Global Healthcare Conference

May 22, 2007
BD Board Declares Dividend

May 22, 2007
BD Demonstrates Microbiology Automation Designed to Improve Laboratory Efficiency of Microbial Identification and Susceptibility Testing

May 21, 2007
BD Receives CE Mark Approval for Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures

May 18, 2007
BD to Present at the Bank of America 2007 Healthcare Conference

May 17, 2007
BD to Present at the Sanford C. Bernstein & Co., LLC Twenty-Third Annual Strategic Decisions Conference

May 10, 2007
BD Biosciences to Expand Manufacturing in Durham, North Carolina

April 27, 2007
BD Biosciences Earns Top Honors for Flow Cytometry-based Cell Biology Instruments at Prestigious Life Science Industry Awards

April 26, 2007
Variant Strain of Chlamydia May Go Undetected

April 25, 2007
BD Discloses Notice of Arbitration and Dispute Resolution Proceedings

April 25, 2007
BD Announces FDA 510(k) Submission of Two Hour Test to Identify Superbug in Patients with Positive Blood Cultures

April 25, 2007
BD Announces Results for Second Fiscal Quarter

April 18, 2007
BD to Present at the 2007 Morgan Stanley Global Healthcare Unplugged Conference

March 28, 2007
BD Medical Launches the BD AutoShield™ Pen Needle

March 26, 2007
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call

March 26, 2007
BD and Direct Relief International Launch Volunteer Service Program to Improve Healthcare in Ghana

March 22, 2007
BD and FIND Announce Expanded Collaboration to Improve Tuberculosis Diagnostics Worldwide

March 13, 2007
BD Move Signals Commitment to Oxford

March 09, 2007
BD Honored as One of "America's Most Admired Companies" in FORTUNE Magazine's Annual Rankings

March 01, 2007
BD to Present at the Cowen and Company 27th Annual Healthcare Conference

February 26, 2007
BD Biosciences and Roche Collaborate to Advance the Study of Cell Signal Transduction through New Phosphorylation Site Antibody Targets and Applications

February 14, 2007
BD Announces 2007 BD Biosciences Technology Days

February 08, 2007
BD Commits $34 Million for Major Expansion in Québec

February 07, 2007
BD Medical Creates BD FluStock(SM) Planning Service to Aid Pandemic Influenza Preparedness Efforts in Hospitals

January 30, 2007
BD Board Declares Dividend

January 30, 2007
BD Announces Results of Shareholder Votes at Annual Meeting

January 30, 2007
BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference

January 25, 2007
BD Announces Results for First Fiscal Quarter

January 11, 2007
BD Announces Webcast of Annual Meeting of Shareholders

December 28, 2006
BD to Present at the 25th Annual JPMorgan Healthcare Conference

December 21, 2006
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call

December 20, 2006
BD Completes Acquisition of TriPath Imaging

November 30, 2006
BD and International Council of Nurses Collaborate to Address the Health Human Resource Crisis in Africa

November 21, 2006
BD Board Declares Dividend

November 20, 2006
BD to Present at the Lazard Capital Markets Third Annual Life Sciences Conference

November 11, 2006
Responding to the Needs of the Ophthalmic Surgical Team: BD Provides Enhanced Safety Solutions

November 06, 2006
BD to Present at the ArgusVision 2007: Eyes on the Future Conference

November 02, 2006
BD Announces Results for Fourth Fiscal Quarter and Full Year

November 01, 2006
BD to Present at the CIBC World Markets Seventeenth Annual Healthcare Conference

October 30, 2006
BD Biosciences Announces Immunology Grant Program Winners

October 19, 2006
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call

October 17, 2006
BD Medical Worksite Diabetes Prevention Program Yields Successful Results

September 28, 2006
BD Announces Plan to Exit Blood Glucose Monitoring Market

September 26, 2006
BD Board of Directors Elects Dr. Claire M. Fraser-Liggett

September 18, 2006
BD Biosciences Releases BD FACSCanto™ II Flow Cytometry System for In Vitro Diagnostics Use

September 14, 2006
BD Medical Extends Broader Offering of Needle Technology Designed to Improve Patient Comfort and Healthcare Worker Safety

September 08, 2006
BD to Acquire TriPath Imaging, Inc.

September 05, 2006
BD to Present at the Bear Stearns 19th Annual Healthcare Conference

August 31, 2006
BD to Present at the Thomas Weisel Partners Healthcare Conference 2006

August 14, 2006
BD Makes Filing to Report Bid to Acquire TriPath Imaging, Inc.

August 12, 2006
Research Shows CD4 Testing Cost-Effective for HIV Patients in Areas Lacking Access to Second-Line ARV Treatments

August 12, 2006
BD Diagnostics Announces Availability in Africa of New CD4 Stabilization Blood Collection Technology

August 09, 2006
BD Biosciences Empowers Advances in Immune System Disease Research

August 08, 2006
MedCentral Health System Implements BD.id™ Patient Identification System for Specimen Management

August 07, 2006
BD Biosciences Announces Extension of Grant Program for Immunology Researchers

July 28, 2006
CEO Ed Ludwig Discusses Third Fiscal Quarter Results on CNBC (Video)

July 28, 2006
BD Announces Results for Third Fiscal Quarter

July 25, 2006
BD Board of Directors Elects Dr. Adel A.F. Mahmoud

July 25, 2006
BD Board Declares Dividend

July 21, 2006
Wyeth Infant Meningitis Vaccine Available for Delivery with BD Hypak SCF™ Prefill System

July 18, 2006
BD Invests US$16 Million to Establish a Plant in China To Produce Rapid Diagnostic Products for Flu and Virus Infection

July 17, 2006
25 Years of Manufacturing Excellence in Plymouth

July 17, 2006
BD Medical Announces Positive Results for New York City BD Diabetes Makeover(SM) Program

June 15, 2006
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call

June 15, 2006
BD Diagnostics Announces Agreement with BioReference Laboratories for BD Viper™ Robotic Instrumentation and Molecular Testing of Sexually Transmitted Infections

June 12, 2006
BD and Catholic Medical Mission Board Partner to Bolster Zambian Healthcare Clinics' HIV/AIDS Efforts

June 06, 2006
BD to Present at the Goldman Sachs 27th Annual Global Healthcare Conference

May 23, 2006
BD Board Declares Dividend

May 10, 2006
BD to Present at the Bank of America Healthcare Conference 2006

April 26, 2006
BD Announces Results for Second Fiscal Quarter

April 24, 2006
BD to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2006

April 12, 2006
BD Develops Its Global Manufacturing Centre in Drogheda

April 06, 2006
NYC's North General Hospital to Host BD Diabetes Makeover Program

March 28, 2006
BD Biosciences Announces Agreement with Dynomics to Collaborate on Novel Cancer Diagnostic Technology

March 27, 2006
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call

March 20, 2006
BD Medical to Support Gary Hall, Jr. Through 2008 Olympic Games

March 06, 2006
BD to Present at the SG Cowen & Co. 26th Annual Health Care Conference

February 23, 2006
BD Diagnostics Announces Multi-year Agreement with Quest Diagnostics for BD Viper™ System

February 17, 2006
BD Medical Notifies Blood Glucose Monitor Users in the US and Canada About a Potential Malfunction with its Meters

February 14, 2006
BD Completes Acquisition of GeneOhm Sciences, Inc.

January 31, 2006
BD Medical Continues Advancement of Flu Vaccine Delivery Technologies

January 31, 2006
BD Board Declares Dividend

January 30, 2006
BD Medical Announces New Regional Anesthesia Tray Business

January 26, 2006
BD Announces Results for First Fiscal Quarter

January 24, 2006
BD Announces Webcast of Annual Meeting of Shareholders

January 10, 2006
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call

January 10, 2006
BD Announces Agreement to Acquire GeneOhm Sciences, Inc.

January 09, 2006
BD Diagnostics Announces FDA 510(k) clearance of the BD Viper™ System

January 04, 2006
BD Blood Glucose Monitors - Product Notification

December 28, 2005
BD to Present at the 24th Annual JPMorgan Healthcare Conference

December 21, 2005
BD Micro-Delivery System Licensed by Sanofi Pasteur

December 20, 2005
BD to Allow Poison Pill to Expire; also Adopts New Policy Regarding Election of Directors

December 13, 2005
BD Diabetes Makeover Program Continues to Yield Positive Results

November 22, 2005
BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases

November 10, 2005
BD Diagnostics and TimeMed Collaborate on First Notched Overlabel for Blood Collection Tubes

November 07, 2005
BD Biosciences to Establish Manufacturing in Puerto Rico

November 07, 2005
BD to Present at the 2005 Credit Suisse First Boston Health Care Conference

November 03, 2005
CEO Ed Ludwig Discusses Fourth Fiscal Quarter and Full Year Results on CNBC

November 03, 2005
BD Announces Results for Fourth Fiscal Quarter and Full Year

November 02, 2005
American Red Cross and BD Announce Expanded Collaboration to Support Measles Initiative

November 02, 2005
BD to Present at CIBC World Markets Healthcare Conference

October 28, 2005
BD Diabetes Makeover Teams with dLife Television

October 25, 2005
BD Expands Research and Data Hub in Research Triangle Park

October 19, 2005
BD Diagnostics Announces FDA 510(k) Clearance for BD ProbeTec™ Urine Preservative Transport

October 18, 2005
BD to Support TIME Global Health Summit, Nov. 1-3, 2005

October 05, 2005
Jackson-Madison County General Hospital to Implement BD.id™ Patient Identification System for Specimen Management

September 27, 2005
BD Diagnostics Announces FDA 510(k) Clearance of BD Directigen™ EZ Flu A+B Test

September 22, 2005
BD Announces Preparation Efforts Ahead of Hurricane Rita

September 20, 2005
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call

September 14, 2005
BD Supplements Hurricane Katrina Relief Contribution with Medical Product Donations

September 01, 2005
BD Donates $500,000 to Hurricane Katrina Disaster Relief Efforts

September 01, 2005
BD to Present at Bear Stearns 18th Annual Healthcare Conference

August 30, 2005
BD to Present at Thomas Weisel Partners Healthcare Tailwinds Conference

August 22, 2005
BD Medical Continues Efforts to Advance Operating Room Safety

August 12, 2005
BD Diabetes Care Announces Successful Results of DC Diabetes Makeover Initiative

July 29, 2005
BD Announces Launch of Online Store

July 27, 2005
Single-Use Blood Collection Devices Help Ensure Safety of Patients and Healthcare Workers (PDF)

July 26, 2005
BD Board Declares Dividend

July 22, 2005
BD Announces Results for Third Fiscal Quarter

July 22, 2005
CEO Ed Ludwig Discusses Results on CNBC

July 13, 2005
BD Diabetes Makeover Program Comes to Nation's Capital

July 01, 2005
BD Announces Agreement to Sell Clontech

June 09, 2005
BD to Present at Goldman Sachs Twenty-Sixth Annual Global Healthcare Conference

May 25, 2005
BD to Establish Major Distribution Center in Plainfield, Indiana

May 24, 2005
BD Board Declares Dividend

May 18, 2005
PreAnalytiX PAXgene™ Blood RNA System is Industry's First to Receive 510(K) Clearance From FDA and to Attain CE Mark

May 18, 2005
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call

May 09, 2005
BD to Present at Banc of America Securities Health Care Conference 2005

May 04, 2005
BD and CMMB Join Forces to Address the Challenge of HIV/AIDS Pandemic in Zambia

May 04, 2005
BD to Present at R. W. Baird 2005 Growth Stock Conference

May 03, 2005
BD Announces Acquisition of Protein Separation Technology from FFE Weber GmbH

April 28, 2005
BD to Present at Morgan Stanley Third Annual Global Healthcare Conference

April 27, 2005
BD Announces Results for Second Fiscal Quarter

April 15, 2005
Pioneer in Blade Technology Introduces First Single-Use Cataract Safety Knife System

March 24, 2005
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call

March 10, 2005
BD to Present at SG Cowen 25th Annual Health Care Conference

March 09, 2005
BD Announces Launch of Two New Monomeric Fluorescent Proteins for Life Science Researchers

February 23, 2005
BD Named One of America's Most Admired Companies in FORTUNE Magazine's Annual Survey

February 17, 2005
BD Commits $31 Million for Major Expansion in Sandy, Utah

February 02, 2005
BD to Present at Merrill Lynch 2005 Global Pharmaceutical, Biotechnology and Medical Device Conference

February 01, 2005
BD Announces Results of Shareholder Votes at Annual Meeting

February 01, 2005
BD Board Declares Dividend

January 28, 2005
BD Statement Regarding Worldwide Voluntary Recall of BD ProbeTec™ ET Urine Processing Kits

January 26, 2005
BD Announces Webcast of Annual Meeting of Shareholders

January 26, 2005
BD Announces Results for Fiscal First Quarter

January 20, 2005
BD to Present at 17th Annual Piper Jaffray Health Care Conference

January 14, 2005
BD Announces Live Webcast Of First Fiscal Quarter Earnings Conference Call

January 10, 2005
BD Announces FDA 510(k) clearance of simplified test for detection of methicillin-resistant Staphylococcus aureus (MRSA)

January 05, 2005
BD to Present at 23rd Annual JPMorgan Healthcare Conference

January 04, 2005
BD Announces Tsunami Relief Efforts

December 20, 2004
BD Biosciences Supports World AIDS Day

December 16, 2004
Hindustan Latex and BD Launch Auto-Disable Syringes in India

December 15, 2004
FIND and BD Combine International Efforts to Improve Rapid Tuberculosis Diagnosis for HIV-positive Patients in Developing Countries

November 23, 2004
BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases

November 23, 2004
BD Board of Directors Elects Gary A. Mecklenburg

November 22, 2004
BD Releases New Version of BD.id™ Patient Identification System for Specimen Management

November 12, 2004
BD Commits to Major Expansion in Columbus, Nebraska

November 11, 2004
Meeting the Challenge of Influenza

November 09, 2004
Cellomics and BD Sign License Agreement to Further Expand Availability of High Content Screening

November 05, 2004
BD Presents Diabetes Makeover to Inspire Better Diabetes Care

November 04, 2004
BD Announces Fiscal Fourth Quarter and Full Year Results

November 04, 2004
FDA Alternate Site Clearance Offers BD Blood Glucose Meter Users More Convenience

October 26, 2004
BD to Present at CIBC World Markets Healthcare Conference

October 14, 2004
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call

October 06, 2004
BD Launches Dora the Explorer™ Digital Thermometer

October 04, 2004
BD Announces Plan to Sell Clontech

September 21, 2004
BD Biosciences Releases BD FACSCanto™ Flow Cytometry System for Clinical Diagnostics

September 16, 2004
BD to Present at UBS Global Life Sciences Conference

September 07, 2004
BD to Present at Bear Stearns 17th Annual Healthcare Conference

September 02, 2004
BD to Present at Thomas Weisel Partners Healthcare Tailwinds 2004 Conference

September 01, 2004
2004 Olympic Gold-Medalist Swimmer Gary Hall Jr. Joins Forces with BD to Inspire Americans to Improve Their Diabetes Care

July 27, 2004
BD, Sumter County Announce Major Facility Expansion

July 27, 2004
BD Biosciences Pharmingen Designated One of the Best Workplaces for Commuterssm by U.S. EPA and DOT

July 27, 2004
BD Board Declares Dividend

July 22, 2004
BD Announces Results for Fiscal Third Quarter

July 12, 2004
BD Highlights Social Responsibility in First Global Corporate Citizenship Report

July 08, 2004
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call

July 02, 2004
BD Announces Settlement of Pending Lawsuit

July 01, 2004
BD Announces Acquisition of Atto Bioscience, Inc.

June 29, 2004
BD Applauds President's Inclusion Of Vietnam In Global Strategy To Combat HIV/AIDS

June 28, 2004
BD FACSArray™ Bioanalyzer is Honored with a 2004 Silver Industrial Design Excellence Award

June 16, 2004
BD Receives Medical Design Excellence Award - Wireless Blood Glucose Monitor Recognized for Innovation, Design Excellence

June 16, 2004
Norwalk Hospital to Implement BD.id™ Patient Identification System for Specimen Management

June 14, 2004
BD Names J. Peter Natale as Chief Information Officer

June 14, 2004
BD Continues to Lead the Way in Drug Delivery Technologies: Launches New Generation of Plastic Prefillable Syringes

June 10, 2004
BD Submits 510(k) Application to FDA for Alternate Site Testing

June 02, 2004
BD to Present at Goldman Sachs Twenty Fifth Annual Global Healthcare Conference

May 25, 2004
BD Board Declares Dividend

May 24, 2004
BD Announces FDA 510(k) Clearance of Molecular Test for Legionella pneumophila

May 12, 2004
BD to Present at Banc of America Securities 2004 Health Care Conference

May 11, 2004
BD Biosciences Releases the BD FACSCanto™ Flow Cytometry System

May 04, 2004
BD™ Sharps Disposal By Mail System Meets EPA Guidelines, Helps Protect Public Against Injury, Infection

April 30, 2004
BD to Present at Morgan Stanley Second Annual Global Healthcare Unplugged Conference

April 22, 2004
BD Announces Fiscal Second Quarter Results

April 08, 2004
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call

March 29, 2004
Basil L. Anderson Elected to BD Board of Directors

March 04, 2004
Hepatitis C Treatment Available in Self-Dosing Pen Format

February 26, 2004
BD to Present at the SG Cowen 24th Annual Health Care Conference

February 23, 2004
BD.id™ Patient Identification System Reduces Specimen Collection Errors by 99.95% at The Valley Hospital

February 04, 2004
BD Announces Launch of 1ml Retracting Syringe

January 29, 2004
BD Announces Fiscal First Quarter Revenue and Earnings Growth

January 29, 2004
BD Initiates Voluntary Recall of Certain BD™ Test Strips

January 28, 2004
BD to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference

January 27, 2004
BD Board Declares Dividend

January 27, 2004
BD Board Authorizes Additional Share Repurchases

January 13, 2004
BD to Announce First Fiscal Quarter Results

December 29, 2003
BD Names Jeffrey S. Sherman Vice President and General Counsel

December 02, 2003
BD to Present at Merrill Lynch Medical Technology University Conference

November 24, 2003
BD Board Declares Dividend Increase of 50%

November 06, 2003
BD Announces Record Fiscal Fourth Quarter and Full Year Revenues

November 06, 2003
BD Applauds Senate Action To Prevent Unsafe Medical Practices That Can Cause HIV/AIDS Spread In Africa

November 05, 2003
BD to Present at Credit Suisse First Boston's Health Care Conference

November 05, 2003
BD to Announce Fourth Fiscal Quarter and Year-End Results

November 04, 2003
BD to Present at the CIBC World Markets Fourteenth Annual Healthcare Conference

October 30, 2003
BD Supplemental Statement Regarding Voluntary Recall of BD ProbeTec™ ET Instrument

October 29, 2003
BD Introduces New BD Ultra-Fine™ II, Thinnest Insulin Syringe Needle Available In US

October 07, 2003
Park City Solutions Joins BD to Co-Market BD.id™ Patient Identification System

September 04, 2003
BD to Present at the Bear Stearns 16th Annual Healthcare Conference

August 29, 2003
BD to Present at Thomas Weisel Partners Healthcare Tailwinds 2003 Conference

August 22, 2003
BD Statement Regarding Voluntary National Recall of BD ProbeTec™ ET Instrument

July 31, 2003
BD to Present at Adams, Harkness & Hill 23rd Annual Summer Seminar

July 24, 2003
BD Announces Results for Fiscal Third Quarter

July 22, 2003
BD Board Declares Dividend

June 30, 2003
BD to Announce Third Fiscal Quarter Results

June 05, 2003
BD to Present at Goldman Sachs Twenty Fourth Annual Global Healthcare Conference

May 20, 2003
BD Board Declares Dividend

May 01, 2003
BD to Present at the 2003 Deutsche Bank Securities Health Care Conference

April 25, 2003
BD Announces Fiscal Second Quarter Results

April 25, 2003
Webcast Replay - BD 2Q Earnings Conference Call, April 25, 2003, 8:30 AM ET

April 24, 2003
BD to Present at Morgan Stanley 1st Annual Healthcare Unplugged Conference

April 22, 2003
Edward F. DeGraan Elected to BD Board of Directors

April 16, 2003
BD Announces Plans for Discontinuation of Conventional Needle Sales in US Across Many Product Categories

April 15, 2003
BD CEO Edward J. Ludwig Selected to Serve on US-Japan Private Sector / Government Commission

April 02, 2003
BD to Announce Second Fiscal Quarter Results

March 18, 2003
BD to Present at the SG Cowen 23rd Annual Health Care Conference

March 14, 2003
BD Names Vincent A. Forlenza President of BD Biosciences

February 05, 2003
BD Comments Further on West Pharmaceutical Services Plant Incident

February 03, 2003
BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference

January 29, 2003
BD Statement in Response to West Pharmaceutical Services Plant Incident

January 28, 2003
BD Board Authorizes Additional Share Repurchases

January 28, 2003
BD Board Declares Dividend

January 23, 2003
BD Announces Results for Fiscal First Quarter

January 16, 2003
BD to Announce First Fiscal Quarter Results

January 08, 2003
BD Presents New Blood Glucose Monitoring Products and Announces Strategic Relationships with Medtronic MiniMed and Eli Lilly and Company

January 08, 2003
BD Introduces New Systems to Make Diabetes Monitoring and Management Easier, Faster, and Less Painful

December 10, 2002
BD to Present New Blood Glucose Monitoring Products

November 26, 2002
BD Board Declares Increased Dividend

November 06, 2002
BD Announces Record Fiscal Fourth Quarter and Full Year Revenues

November 05, 2002
BD to Present at Credit Suisse First Boston Healthcare Conference

October 21, 2002
BD to Announce Fourth Fiscal Quarter and Year-End Results

October 16, 2002
NJ Governor announces agreement to pilot-test BD Bio-Terror Preparedness Network

September 24, 2002
Bertram L. Scott Elected to BD Board of Directors

September 23, 2002
BD™ Bifurcated Needle Launched for Smallpox Vaccination Efforts

September 04, 2002
BD Director Albert J. Costello Dies at 66

August 13, 2002
CEO and CFO submit certifications pursuant to SEC Order and Sarbanes-Oxley Act of 2002

August 12, 2002
CEO and CFO submit sworn statements pursuant to SEC Order regarding SEC filings

July 26, 2002
U.S. Fund for UNICEF and BD Partner to Accelerate Elimination of Maternal and Neonatal Tetanus

July 24, 2002
Letter to the Editor from Chairman, President and CEO Edward J. Ludwig in response to The New York Times article of July 19

July 24, 2002
BD Announces Results for Fiscal Third Quarter

July 23, 2002
BD Declares Dividend

July 19, 2002
Statement from BD in response to The New York Times article

May 21, 2002
BD Declares Dividend

April 24, 2002
BD Announces Record $1 Billion Second Quarter Revenues

April 16, 2002
BD Biosciences and NuGenesis Technologies Announce Strategic Alliance...

April 09, 2002
BD Announces New Safety-Engineered Product Technology

April 01, 2002
Wesley J. Howe, Former BD CEO, Dies at 80

March 26, 2002
BD to Present at Banc of America Securities Healthcare Conference

January 29, 2002
BD Biosciences Enters Into Collaboration With the Harvard Institute of Proteomics to Determine Human Gene Function

January 29, 2002
BD to Present at Merrill Lynch Healthcare Conference

January 23, 2002
BD Announces Results for Fiscal First Quarter

January 22, 2002
BD Declares Dividend

January 04, 2002
BD to Present at JP Morgan H&Q Healthcare Conference

January 03, 2002
BD to Announce First Fiscal Quarter Results

November 27, 2001
Edward J. Ludwig to Become BD Chairman of the Board Effective February 2002

November 27, 2001
BD Declares Increased Dividend

November 08, 2001
BD to Present at CSFB Health Care Conference

November 07, 2001
BD Announces Record Fiscal Fourth Quarter Revenues

October 30, 2001
BD to Announce Fourth Fiscal Quarter and Year-End Results

September 26, 2001
BD to Present at Bear Stearns Virtual Healthcare Conference

September 24, 2001
BD Pledges $1,000,000 to Help Victims and Families; Launches Worldwide Employee Contributions Campaign

September 17, 2001
BD Board Authorizes Additional Share Repurchases

September 04, 2001
BD to Present at Banc of America Securities Investment Conference

July 30, 2001
BD Biosciences To Collaborate With Zyomyx To Apply Antibody Expertise To High Density Protein Biochips

July 25, 2001
BD To Present at Adams, Harkness & Hill Summer Seminar

July 24, 2001
BD Declares Dividend

July 18, 2001
BD Announces Results For Fiscal Third Quarter

June 20, 2001
BD Congratulates GlaxoSmithKline on Receiving FDA Approval To Market Prefilled Vaccine System

June 13, 2001
BD Biosciences and Dyax Corp. Announce Research Products and Proteomics Alliance

June 07, 2001
BD To Present at Goldman Sachs Healthcare Conference

June 04, 2001
Nanogen/BD Joint Venture Awarded Its First U.S. Patent

June 01, 2001
BD Technologies Hosts Incubator Program Graduation Ceremonies

May 22, 2001
BD Declares Dividend

May 05, 2001
New UNICEF Greeting Card Celebrates a Mother's Love

April 18, 2001
BD Announces Record Revenues for Fiscal Second Quarter

April 04, 2001
BD Announces Plans To Introduce Passive, Shielded I.V. Catheter

March 22, 2001
BD To Present at Banc of America Securities Healthcare Conference

February 22, 2001
BD To Present at Lehman Brothers Healthcare Conference

February 01, 2001
BD To Present At Merrill Lynch Conference

January 23, 2001
BD Names Dean Paranicas Vice President, Investor Relations and Public Affairs

January 23, 2001
BD Declares Dividend

January 22, 2001
BD to Present at U.S. Bancorp Piper Jaffray Health Care Conference

January 17, 2001
BD Announces Results for Fiscal First Quarter

January 11, 2001
BD Announces Webcast of Q1 Conference Call

December 20, 2000
BD Signs Agreement to Acquire Gentest Corporation

December 15, 2000
Edward J. Ludwig Appointed to U.S. Fund for UNICEF Board of Directors

December 14, 2000
BD Names First Winners of Wesley J. Howe Award for Technological Innovation

November 28, 2000
BD Praises Recent California Patient Safety Legislation

November 28, 2000
BD Elects James Orr to Board of Directors

November 28, 2000
BD Declares Increased Dividend

November 13, 2000
BD to Present at CSFB Annual Healthcare Conference

November 06, 2000
President Clinton Signs Needlestick Safety and Prevention Act;
BD Celebrates Healthcare Worker Safety Law


November 06, 2000
BD Announces Record Revenues For Fiscal Fourth Quarter and Full Year

November 02, 2000
Live Web Cast of BD Presentation to Investment Community

October 27, 2000
BD Praises Senate Passage of Needlestick Safety and Prevention Act

September 26, 2000
BD Names Stephen Mock Vice President, Investor and Public Relations

September 26, 2000
BD Announces Program To Reduce Costs, Improve Financial Performance And Support Major Product Initiatives

September 20, 2000
BD Commends Introduction of New Needlestick Prevention Bill

August 14, 2000
Hepatitis B Immunization Campaign Launched in Indonesia Using BD Uniject™ Injection Device

July 25, 2000
BD Declares Dividend

July 20, 2000
BD Announces Results For Third Fiscal Quarter -- Safety and Biosciences Sales Add To Top Line Growth

July 19, 2000
BD Launches Safety Compliance Initiative for Needlestick Prevention

June 29, 2000
BD Applauds Consensus on Needlestick Prevention Legislation and Health Care Worker Safety at Congressional Hearing

June 05, 2000
BD Wins Major Patent Infringement Lawsuit

June 05, 2000
BD Names Bridget Healy General Counsel

May 30, 2000
BD Names John Considine Executive VP and Chief Financial Officer

May 23, 2000
BD Declares Dividend

April 25, 2000
Chlamydia and Gonorrhea Now Simple to Diagnose

April 24, 2000
BD Named Official Supplier by Major League Soccer (MLS)

April 19, 2000
BD Provides Unrestricted Grant to Support Needle Safety Campaign

April 18, 2000
BD Announces Strong Results for Second Fiscal Quarter and Confirms Outlook for Year

April 17, 2000
BD, Guidant, and Boston Scientific Join Leading Healthcare Companies
New E-Business Venture


April 13, 2000
"The Latest Injection and Blood Collection Advancements" featuring BD products on CNBC

March 21, 2000
Patient Safety at Your Fingertips; BD Develops Hand-Held Device Solutions to Reduce Medication Errors

February 24, 2000
Hospital Risk Managers Find Medication Error a Significant Problem; BD Survey Reveals Reporting Errors Not Rewarded

February 23, 2000
BD Expects Rapid Resumption of Product Supply Following Voluntary Recall; Offers Alternate Product at No Charge in Interim and Confirms E.P.S. Expectations

January 26, 2000
BD Declares Dividend

January 20, 2000
BD Reports Results for Fiscal First Quarter; Revenues Increase 12 Percent

January 06, 2000
New Jersey Governor Whitman Signs Needle Safety Bill

December 22, 1999
BD Makes Additional Contribution to UNICEF's Partnership to Eliminate Maternal and Neonatal Tetanus Worldwide

December 07, 1999
BD Helps Healthcare Organizations Reduce Medical Errors

November 23, 1999
BD Declares Increased Dividend

November 23, 1999
BD Names Robert M. Hallenbeck VP and General Counsel

November 22, 1999
BD Announces Edward J. Ludwig Elected to the Board of Directors and CEO

November 21, 1999
Bill and Melinda Gates Foundation Joins Unicef and BD in Effort To Prevent Newborn Deaths in Developing World

November 08, 1999
BD Announces FDA Clearance of BDProbeTec™ ET System For the Detection of Chlamydia and Gonorrhea

November 04, 1999
BD (Becton, Dickinson and Company) Announces Record Revenues for Fiscal Year

October 13, 1999
BD Announces Chief Financial Officer Is Leaving the Company

October 05, 1999
Becton, Dickinson and Company and Haselmeier GmbH Agree to Form Joint Venture

September 28, 1999
CIO Magazine Honors BD for Innovative Information Technology Practices

September 23, 1999
Two BD Products Win Design Excellence Awards

September 14, 1999
First Ever FDA-Cleared Breast Self-Examination Pad to Help Women Now Available in Drug Stores and Major Chains Nationwide

September 08, 1999
The International Diabetes Center and BD Fortify Staged Diabetes Management Collaboration

August 31, 1999
BD and QIAGEN Agree to form Joint Venture

August 31, 1999
BD Acquires SAF-T-MED Advanced Safety Needle Technology

August 26, 1999
Becton, Dickinson and Company Completes Acquisition of Clontech Laboratories, Inc.

August 18, 1999
Becton Dickinson Introduces a New Global Healthcare Brand

July 21, 1999
Becton Dickinson Reports Third Quarter Results

July 05, 1999
Gaida Joins BD Healthcare Consulting & Services

June 16, 1999
Becton Dickinson Announces National Agreement with Kaiser Permanente

June 11, 1999
Join Becton Dickinson at APIC'99
June 21-23, Hyatt Regency, Baltimore, MD


May 25, 1999
Becton Dickinson Names Ludwig President

May 25, 1999
Becton Dickinson Announces Election of Willard J. Overlock, Jr.

May 12, 1999
Becton Dickinson Introduces The MICROTAINER® Brand GENIE™ Lancet

May 03, 1999
BD Labware and Kimble/Kontes announce the formation of a collaborative agreement.

April 28, 1999
Becton Dickinson and Company Announces Planned Acquisition of Clontech Laboratories, Inc.

April 09, 1999
Becton Dickinson Enters Into Collaborative Drug Delivery Agreements with Rhône-Poulenc Rorer

March 15, 1999
Becton Dickinson Presents Award at LabAutomation99

March 15, 1999
Becton Dickinson Biosciences Leukemia and Lymphoma Product Development Team Volunteers Time at Leukemia Society of America's Cure-a-Thon

March 09, 1999
B-D.id and CAP Today Co-Sponsor Survey to Determine Awareness of Medication Administration and Specimen Collection Errors

March 01, 1999
Becton Dickinson Expands Growing Anesthesia Business With Acquisition of Kendall Anesthesia Product Line

February 25, 1999
BD Enters Molecular Oncology Alliance with Millennium Predictive Medicine

February 09, 1999
Becton Dickinson and Company Announces the Acquisition of Biometric Imaging

February 04, 1999
Becton Dickinson Supports Operation Smile's "World Journey of Hope '99"

February 04, 1999
Becton Dickinson Introduces Plastic-Coated Micro-Hematocrits

February 02, 1999
Becton Dickinson Introduces Quikheel™ Lancets for Infants and Preemies

February 02, 1999
Becton Dickinson Introduces the VACUTAINER® Brand ECLIPSE™ Blood Collection Needle

January 26, 1999
Becton Dickinson Acquires Luther Medical Products

January 26, 1999
Becton Dickinson Declares Dividend

January 21, 1999
Asia's Largest Hypodermic Manufacturing Facilities Established In Bawal, Haryana

January 21, 1999
Becton Dickinson Reports 16 Percent E.P.S. Increase For Fiscal First Quarter; Revenues Increase 10 Percent

January 01, 1999
BD to Present at CIBC World Markets Healthcare Conference

December 14, 1998
Becton Dickinson Acquires New Advanced Protection Technology

November 23, 1998
Becton Dickinson Declares Increased Dividend

November 13, 1998
Castellini Receives Award in Singapore

November 05, 1998
Becton Dickinson Announces Record Revenues For Fiscal Year

October 22, 1998
Becton Dickinson Donation Supports Romanian Measles Elimination Campaign

September 03, 1998
Becton Dickinson Creates Single Bioscience/Diagnostic Business

August 14, 1998
Becton Dickinson Selected by IndustryWeek Magazine as One of the World's 100 Best-Managed Companies

August 05, 1998
Becton Dickinson and Company Announces Executive Vice Presidents; New Chief Financial Officer Named

July 28, 1998
Becton Dickinson Declares Stock Split and Quarterly Dividend

July 21, 1998
Becton Dickinson Reports Third Quarter Results; Record Revenues Increase 18 Percent

June 07, 1998
A Partnership in Diabetes - Becton Dickinson Employees Walk in JDF Walkathon

May 20, 1998
Becton Dickinson Announces Election of Alfred Sommer to Board of Directors

May 19, 1998
Becton Dickinson and Company Announces Restructuring Plan, One-Time Charges For Third Fiscal Quarter

May 19, 1998
Becton Dickinson Declares Dividend

May 11, 1998
New BACTEC™ MGIT™ 960 Is The World's First Automated System For High-Volume Mycobacteria Growth, and Detection

April 21, 1998
Becton Dickinson Reports 13 Percent E.P.S. Increase For Fiscal Second Quarter; Revenues Grew Six Percent

April 03, 1998
Becton Dickinson Completes Acquisition of Medical Devices Division of The BOC Group

March 20, 1998
Incoming chairman says FDA Modernization Act has 'opened door' to new challenges

March 20, 1998
Becton Dickinson Engineers Team Up with Students in 1998 FIRST Robotics Competition

March 13, 1998
Becton Dickinson and Company Introduces the B-D™ ULTRA-FINE™ II Lancet

January 29, 1998
Becton Dickinson Signs Definitive Agreement to Acquire Medical Devices Division of the BOC Group

January 27, 1998
Becton Dickinson and Baxter Announce Joint Marketing Effort

January 26, 1998
Becton Dickinson Acquires Tru-Fit

January 22, 1998
Becton Dickinson Announces Record Fiscal First Quarter Results

December 22, 1997
Five-Year Contract Signed With SmithKline Beecham

December 08, 1997
Becton Dickinson Joins EPA's Energy Star Program

November 25, 1997
Becton Dickinson Declares Increased Dividend

November 06, 1997
Becton Dickinson Announces Record Results For Fiscal Year

October 27, 1997
Becton Dickinson Sponsors China's First Five-Year Diabetes Education Program

October 20, 1997
Galiardo Briefs Investors On Industry Issues

September 15, 1997
Centennial Celebration in Franklin Lakes, New Jersey

September 11, 1997
FDA Clears Becton Dickinson Diabetes Measurement Kit For Marketing

September 09, 1997
Bell Rings for BDX at the NYSE Close

July 22, 1997
Becton Dickinson Initiates Compass Project

July 22, 1997
Becton Dickinson Declares Dividend

July 21, 1997
Becton Dickinson Reports Third Quarter Results; One-Time Charges Reduce E.P.S. By $.11

June 02, 1997
Becton Dickinson Announces Completion of Acquisition of Difco Laboratories

May 28, 1997
Willard Scott of the Today Show sings "Happy Birthday" to us!

May 27, 1997
Becton Dickinson Announces Election of Margaretha af Ugglas to Board of Directors

May 20, 1997
Becton Dickinson Declares Dividend

May 19, 1997
Becton Dickinson and Pharmingen Announce Completion of Acquisition

April 17, 1997
Becton Dickinson Reports 15 Percent E.P.S. Increase for Fiscal Second Quarter

April 10, 1997
Three Named as Honorees in 1997 Tribute to Women and Industry (TWIN)

April 10, 1997
Becton Dickinson and Company Signs Definitive Agreement to Acquire PharMingen

March 26, 1997
Becton Dickinson Sponsors Student Team in FIRST Competition

March 19, 1997
Becton Dickinson and Company Signs Definitive Agreement to Acquire Difco Laboratories Incorporated

January 22, 1997
Becton Dickinson Reports 31 Percent Net Income Increase for Fiscal First Quarter

January 21, 1997
BDSCS Launches ONES Initiative

December 04, 1996
Sandy Facility First To Receive ISO 14001 Certification

November 12, 1996
Fresenius Buys Vial Medical Infusion Systems

November 07, 1996
Becton Dickinson Announces Record Results for Fiscal Year

November 05, 1996
Community Service Awards Announced

November 01, 1996
Opening Ceremonies Held in China

October 24, 1996
Investment in India Increased to $100 Million

October 04, 1996
BDRC Scientist Recognized

 

Unless otherwise noted, BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. © 2014 BD